Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces prostate size and PSA levels in young patients.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Hair loss in men and women can be treated with medications and therapies, showing improvement after 6 months.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

Melatonin may reduce skin damage caused by X-rays in rats.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Estazolam reduces anxiety-like behavior in PTSD by increasing allopregnanolone levels.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Berberine may reduce prostate enlargement by blocking inflammation.

Finasteride helps reduce heart enlargement in heart failure patients.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Testosterone reduces key molecules needed for early pregnancy in rats.

Testosterone reduces heart damage and inflammation after injury.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Calcium reduces involucrin in rat hair bulbs but doesn't affect filaggrin and Kdap.

Metformin reduces high male hormone levels in women with PCOS.

Jute leaves may help reduce DHT levels, potentially aiding in conditions like hair loss and prostate issues.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Testosterone reduces, while finasteride enhances, morphine's pain relief.